[A field trial with the liquid multicomponent meningococcal vaccine ABC].
The morbidity rates of generalized forms of meningococcal infection in persons immunized with different doses of liquid meningococcal vaccine ABC were compared. The vaccine was introduced subcutaneously by means of a jet injector. Altogether 3,920 males aged 18 years and older were immunized. 1,966 vaccinees received this vaccine in a dose of 200 micrograms and 1,954 vaccinees, in a dose of 400 micrograms. Meningococcal multicomponent vaccine ABC used in these doses showed moderate reactogenicity and did not prevent the development of generalized forms of meningococcal infection.
Levina
L A
LA
Filippov
Iu V
IuV
Vartanian
Iu P
IuP
Ratiner
Iu A
IuA
Salov
V F
VF
D000328:Adult; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D006801:Humans; D007277:Injections, Jet; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control; D009345:Neisseria meningitidis / Q000276:immunology*; D014586:USSR
D001428:Bacterial Vaccines
Polevoĭ opyt s meningokokkovoĭ zhidkoĭ polikomponentnoĭ vaktsinoĭ ABC.